← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Mapp Biopharmaceutical, Inc.
San Diego, CA
$56,906,577
Total funding
31
Grants
Funding over time
peak $5.7M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$55,215,732 · 29
DOD$1,465,845 · 1
CDC$225,000 · 1
By mechanism
R44$17,411,274 · 8
U01$16,041,833 · 2
R01$11,533,974 · 2
R43$5,873,269 · 15
SB1$3,993,353 · 2
—$1,465,845 · 1
Investigators at Mapp Biopharmaceutical, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Monoclonal Immunoprotectants for Select Agents Toxins (Mab-SAT)$3,530,196
U01 · FY2013 · AI
Monoclonal Immunoprotectants for Select Agents Toxins (Mab-SAT)$3,111,286
U01 · FY2012 · AI
Monoclonal Antibodies in Biodefense: Ebola Viruses$1,610,165
U01 · FY2009 · AI
FUNDAMENTAL RESEARCH TO COUNTER WEAPONS OF MASS DESTRUCTION (C-WMD)$1,465,845
· FY2025 · Defense Contract Management Agency
An Antibody Immunoprotectant for Category B Toxins$1,297,816
R01 · FY2014 · AI
An Antibody Immunoprotectant for Category B Toxins$1,265,619
R01 · FY2015 · AI
Monoclonal Antibodies in Biodefense: Ebola Viruses$1,238,148
U01 · FY2007 · AI
An Antibody Immunoprotectant for Category B Toxins$1,225,116
R01 · FY2013 · AI
An Immunoprotectant for Argentine Hemorrhagic Fever$1,204,507
R01 · FY2014 · AI
An Antibody Immunoprotectant for Category B Toxins$1,195,183
R01 · FY2016 · AI
Monoclonal Immunoprotectants for Select Agents Toxins (Mab-SAT)$1,174,260
U01 · FY2011 · AI
An Antibody Immunoprotectant for Category B Toxins$1,172,246
R01 · FY2012 · AI
Monoclonal Immunoprotectants for Select Agents Toxins (Mab-SAT)$1,151,953
U01 · FY2010 · AI
Monoclonal Antibodies in Biodefense: Ebola Viruses$1,111,806
U01 · FY2008 · AI
Monoclonal Antibodies in Biodefense: Ebola Viruses$1,067,924
U01 · FY2006 · AI
An Immunoprotectant for Argentine Hemorrhagic Fever$1,062,202
R01 · FY2015 · AI
An Immunoprotectant for Argentine Hemorrhagic Fever$1,058,986
R01 · FY2016 · AI
Monoclonal Antibodies in Biodefense: Ebola Viruses$1,054,720
U01 · FY2005 · AI
An Immunoprotectant for Argentine Hemorrhagic Fever$1,029,383
R01 · FY2017 · AI
Monoclonal Antibodies for Alzheimer's Immunotherapy$1,023,870
R44 · FY2010 · AG